If I had tried to build all of those things before launching, it would have delayed the app by six months
Lancet (London, England) , 398 (10295), 143155 MOUNJARO TM (Tirzepatide) Injection, for Subcutaneous Use. Access Data FDA , Food and Drug Administration, Gorgojo-Martnez, J
1. Metabolic Regulation (Fat Loss)
While Ser2 of oxyntomodulin and Ala8 of GLP-1 both interacted with TM7 residues, these interactions were stronger with oxyntomodulin due to a persistent hydrogen bond between Ser2 and E387 7.42 and transient hydrogen bonds and van der Waals contacts with K383 7.38 , D372 ECL3 and L384 7.39 (Supplementary Table 3)
The BeatO GLP-1 Weight Loss Program brings together doctor-supervised care, authentic medication and certified nutrition coaching to support sustainable weight loss